Selective inhibition of LRRK2 by MLi2, an ATP-competitive inhibitor induces rapid recycling of RAB10 vesicles, thus reducing endocytic defects caused by hyperactivation of LRRK2 signalling in a murine model of Parkinson disease (Scott et al., 2017). The gene discussed is LRRK2; the disease is Parkinson disease.